04-12-2007

A multi-disciplinary UK consortium of partners including Avecia, Intertek ASG, Lonza, Paraytec and the University of Bradford has recently been awarded research grants by the Technology Strategy Board and the Engineering and Physical Sciences Research Council. The part funded £1M+ project is ...

more

20-02-2006

Avecia announced that it has completed the sale of its Electronic Materials businesses (Ink jet and Electrophotography) to FUJIFILM, having obtained all necessary approvals. This successfully concludes a sale agreement previously announced on 26th December 2005. The disposal includes all ...

more

07-12-2005

Avecia announced that it has completed the sale of its Pharmaceuticals custom synthesis business to Nicholas Piramal India Limited (NPIL), having obtained all necessary approvals. This successfully concludes a sale agreement previously announced on 27th October 2005. NPIL has paid GBP 9.5 ...

more

31-10-2005

Avecia announced that it has signed a definitive agreement to sell its Pharmaceutical custom synthesis business to Nicholas Piramal India Ltd for GBP 9.5 million. The transaction, which will fund the business' UK pension fund deficit of between GBP 8 - 9 m, is subject to regulatory and other ...

more

21-09-2005

KemFine Limited, Finland and Avecia Group Plc announced that KemFine has acquired Avecia Fine Chemicals Limited based in Grangemouth, Scotland. Financial details were not disclosed. The combined business will create a major new force in the global fine chemical sector, with a leading ...

more

24-06-2005

Reaxa Limited, the new catalyst technologies company, formally commenced trading following a successful spin-out from Avecia. Reaxa offers new product platforms for "easier, faster and cleaner chemistry" in pharmaceutical and specialty chemical production. Reaxa is a combined venture between ...

more

03-02-2005

Royal DSM N.V. completed the acquisition of NeoResins, the coating resins business of Avecia. The intention of this acquisition was announced on 14 December 2004. Necessary approvals have been obtained from the relevant authorities. The acquisition fits perfectly in DSM's strategy and means a ...

more

15-12-2004

Royal DSM N.V. intends to acquire NeoResins, the coating resins business of Avecia. It is anticipated that the closing will take place in the first quarter of 2005. The acquisition fits perfectly in DSM's strategy and means a substantial strengthening of DSM's coating resins business, part of ...

more

25-11-2004

Avecia Group Plc of Manchester, England and Copperhead Chemical Company of Tamaqua, Pennsylvania jointly announce that Copperhead has acquired Avecia's Special Drug Mixtures (SDM) business. Details of the transaction were not disclosed. The SDM business is centered on a line of standard and ...

more

20-10-2004

Avecia's EnCat(TM) catalyst technology for pharmaceutical and fine chemical production has won its second major industry award of 2004. A collaboration between Cambridge University, Syngenta, AstraZeneca and Avecia, EnCat(TM) has received the Institute of Applied Catalysis (iAc) innovation ...

more